Home LiteratureArticle Details
PMID: 17485647 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

Neurology ·Vol. 68 ·No. 19 ·2007-05-08 ·Pages 1603-6

Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO

Abstract

Patients with mild cognitive impairment (MCI) have increased risk to develop Alzheimer disease (AD). In AD increased brain amyloid burden has been demonstrated in vivo with PET using N-methyl-[(11)C]2-(4'-methylaminophenyl)-6-hydroxybenzothiazole ([(11)C]PIB) as a tracer. To investigate whether patients with amnestic MCI would show increased [(11)C]PIB uptake, indicating early AD process. We studied 13 patients with amnestic MCI and 14 control subjects with PET using [(11)C]PIB as tracer. Parametric images were computed by calculating the region-to-cerebellum ratio in each voxel over 60 to 90 minutes. Group differences in [(11)C]PIB uptake were analyzed with statistical parametric mapping (SPM) and automated region-of-interest (ROI) analysis. The SPM analysis showed that patients with MCI had significantly higher [(11)C]PIB uptake vs control subjects in the frontal, parietal, and lateral temporal cortices as well as in the posterior cingulate showing the most prominent differences. These results were supported by the automated ROI analysis in which MCI patients showed in comparison with healthy control subjects increased [(11)C]PIB uptake in the frontal cortex (39% increase from the control mean, p < 0.01), the posterior cingulate (39%, p < 0.01), the parietal (31%, p < 0.01) and lateral temporal (28%, p < 0.001) cortices, putamen (17%, p < 0.05), and caudate (25%, p < 0.05). Individually, in the frontal cortex and posterior cingulate, 8 of 13 patients with MCI had [(11)C]PIB uptake values above 2 SD from the control mean. MCI subjects having at least one APOE epsilon4 allele tended to have higher [(11)C]PIB uptake than MCI subjects without APOE epsilon4. At group level the elevated N-methyl-[(11)C]2-(4'-methylaminophenyl)-6-hydroxybenzothiazole ([(11)C]PIB) uptake in patients with mild cognitive impairment (MCI) resembled that seen in Alzheimer disease (AD). At the individual level, about half of the MCI patients had [(11)C]PIB uptake in the AD range, suggestive of early AD process.

MeSH Terms
Aged Alzheimer Disease/diagnostic imaging,metabolism,physiopathology Amnesia/diagnostic imaging,metabolism,physiopathology Amyloid beta-Peptides/metabolism Aniline Compounds Benzothiazoles Brain/diagnostic imaging,metabolism,physiopathology Brain Mapping Cognition Disorders/diagnostic imaging,metabolism,physiopathology Female Humans Male Plaque, Amyloid/diagnostic imaging,metabolism Positron-Emission Tomography/methods Predictive Value of Tests Thiazoles
Chemicals
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole Amyloid beta-Peptides Aniline Compounds Benzothiazoles Thiazoles
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Kemppainen N M
Turku PET Centre, University of Turku, Turku, Finland.
Aalto S
Wilson I A
Någren K
Helin S
Brück A
Oikonen V
Kailajärvi M
Scheinin M
Viitanen M
Parkkola R
Rinne J O
Article Info
Journal
Neurology
Abbr.
Neurology
ISSN
1526-632X
Published
2007-05-08
Pages
1603-6
Language
English
Region
United States
NLM ID
0401060
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com